Антиоксидантная терапия в комплексном управлениисахарным диабетом
Антиоксидантная терапия в комплексном управлениисахарным диабетом
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Балаболкин М.И., Креминская В.М., Клебанова Е.М. Роль окислительного стресса в патогенезе диабетической нейропатии и возможность его коррекции препаратами α-липоевой кислоты. Пробл. эндокринол. 2005; 51 (3): 22–32.
2. Ziegler D, Hanefild M, Ruhnau K et al. The ALADIN III Study Group. Treatment of symptomatic diabetic polyneuropathy with the antioxydant alfa-lipoic acid. A 3 week multicenter randomized controlled trial. Diabetes Care 1999; 22: 1296–301.
3. Reljanovic M, Reichel G, Lobisch M et al. Treatment of diabetic polyneuropathy with the antioxydant thioctic acid (alfa-lipoic acid): a two year. 1999.
4. Rosenberg HR, Culik R. Effect of lipoic acid supplementation on vitamin C and vitamin E deficiencies. Arch Biochem Biophys 1959; 8: 86–93.
5. Jacob S, Ruus P, Hermann R et al., 1999.
6. Балаболкин М.И., Клебанова Е.М. Актуальность витаминно-минеральной терапии. Клин. эндокринол. 2008; 2.
7. Балаболкин М.И., Фадеева Н.И., Мамаева Г.Г. Окислительный стресс и антиоксидантная терапия. 2001.
8. Schmidt J. Wirksamkeit von benfotiamin bei diabetischer neuropathie breite anwendungsbeobachtung unterstreicht praxisbenefit. Der KaSSENARZT, Helt, 2002; 14/15: 40–3.
9. Gadau S, Emanueli C, Van Linthous S et al. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and ingibition of apoptosis. Diabetologia 2006; 49: 405–20.
10. Schreeb KH, Freudenthaler S, Vormfelde SV et al. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 1997; 52: 773–88.
11. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev 2005; 1: 287–98.
12. Thornalley PJ, Jahan I, Ng R. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem 2001; 129: 543–9.
13. Berrone E, Beltramo E, Solimine C et al. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem 2006; 281: 9307–13.
14. Larkin JR, Thornalley PJ. High glucose causes a decrease in expression of thiamine transporters in human proximal tubule epithelial cells in vitro. Diabetologia 2008; 51: S97.
2. Ziegler D, Hanefild M, Ruhnau K et al. The ALADIN III Study Group. Treatment of symptomatic diabetic polyneuropathy with the antioxydant alfa-lipoic acid. A 3 week multicenter randomized controlled trial. Diabetes Care 1999; 22: 1296–301.
3. Reljanovic M, Reichel G, Lobisch M et al. Treatment of diabetic polyneuropathy with the antioxydant thioctic acid (alfa-lipoic acid): a two year. 1999.
4. Rosenberg HR, Culik R. Effect of lipoic acid supplementation on vitamin C and vitamin E deficiencies. Arch Biochem Biophys 1959; 8: 86–93.
5. Jacob S, Ruus P, Hermann R et al., 1999.
6. Балаболкин М.И., Клебанова Е.М. Актуальность витаминно-минеральной терапии. Клин. эндокринол. 2008; 2.
7. Балаболкин М.И., Фадеева Н.И., Мамаева Г.Г. Окислительный стресс и антиоксидантная терапия. 2001.
8. Schmidt J. Wirksamkeit von benfotiamin bei diabetischer neuropathie breite anwendungsbeobachtung unterstreicht praxisbenefit. Der KaSSENARZT, Helt, 2002; 14/15: 40–3.
9. Gadau S, Emanueli C, Van Linthous S et al. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and ingibition of apoptosis. Diabetologia 2006; 49: 405–20.
10. Schreeb KH, Freudenthaler S, Vormfelde SV et al. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 1997; 52: 773–88.
11. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev 2005; 1: 287–98.
12. Thornalley PJ, Jahan I, Ng R. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem 2001; 129: 543–9.
13. Berrone E, Beltramo E, Solimine C et al. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem 2006; 281: 9307–13.
14. Larkin JR, Thornalley PJ. High glucose causes a decrease in expression of thiamine transporters in human proximal tubule epithelial cells in vitro. Diabetologia 2008; 51: S97.
Авторы
Н.А.Черникова, Б.С.Абаева, М.А.Прудникова, Е.В.Сучкова
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.